ProstatID, THE AI software FDA-cleared for not only detection and diagnosis of PCa, but also for screening using bpMRI. Yes, ‘screening’ because it is low-cost, very effective (94% accurate), and also very accessible with plenty of MRI magnet time available in the US. The Standard of Care is constantly changing and according to the just released NEJM article titled “Fifteen-year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer” which concluded that people with low to intermediate risk for cancer should carefully weigh their treatment timing and options because the treatment can be worse than watching and waiting. ProstatID identifies, segments and risk stratifies every suspect lesion in the prostate MRI, as well as provides a case (PI-RADs) score, prostate volume and lesion volumes on a report supplement – all in less than 5 minutes after receiving the study via a secure, HIPAA compliant VPN tunnel OR via installation behind your firewall. Kick start or quickly increase your prostate cancer detection and screening program wit Bot Image’s ProstatID with a low cost fee per click or volume discounted annual agreement.
Contact [email protected] for more information.